Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. Right now, patients with obesity and cirrhosis ...

Steatotic liver disease (commonly called fatty liver disease) progresses silently. Even in the absence of noticeable symptoms ...

Familial hypobetalipoproteinemia (FHBL), caused by apolipoprotein B (APOB) variants, disrupts APOB-containing lipoprotein ...

Newly discovered mechanism by which oral bacteria affect gut health coincides with worsening liver health in patients with ...

Myosteatosis, the pathological infiltration of fat into skeletal muscle, is increasingly recognized as a key predictor of ...

New data links the liver receptor GPR110 to sex-specific progression of metabolic dysfunction-associated steatohepatitis.

Fatty liver disease has become one of the most common silent diseases in our country, but this daily drink can help improve ...

The placebo-controlled, double-blind, randomised Phase I trial involved 100 healthy participants.

You've probably heard it a hundred times: swap white sugar for honey, agave, or fruit juice and you're making a healthier ...

The FDA expanded the indication for semaglutide (Wegovy) to treating adults with noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), the agency announced. The glucagon-like peptide-1 ...

Fatty liver disease is not restricted to adults, and its incidence in children and adolescents is continuously increasing.

New analysis shows alcohol-related liver disease remains a major cause of cirrhosis and liver death. Read more.